TABLE 2: Antimicrobial susceptibility profile of E. cloacae, E. coli and K. pneumoniae isolates per site.
| Antimicrobial susceptibility | JB | CL | TL | AL | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| Enterobacter cloacae (total) | 17 | 13 | 26 | 9 | 65 | |||||
| Resistant (R/I) | ||||||||||
| SAM | 16 | 94 | 13 | 100 | 9 | 34 | 5 | 56 | 34 | 52 |
| SAM, IPM, HODGE + | - | - | - | - | 2 | 8 | - | - | 2 | 3 |
| SAM, MEM, HODGE + | - | - | - | - | 2 | 8 | - | - | 2 | 3 |
| SAM, ETP, HODGE + | - | - | - | - | 13 | 50 | - | - | 13 | 20 |
| GEN | - | - | - | - | - | - | 2 | 22 | 2 | 3 |
| Susceptible | 1 | 6 | - | - | - | - | 2 | 22 | 3 | 5 |
| Escherichia coli (total) | 5 | 21 | 2 | 3 | 31 | |||||
| Resistant (R/I) | ||||||||||
| SAM | - | - | - | - | - | - | 1 | 33 | 1 | 3 |
| SAM, FEP, CXM, CXA, CAZ, CRO, ESBL+ | - | - | 2 | 10 | - | - | - | - | 2 | 6 |
| Susceptible | 5 | 100 | 19 | 90 | 2 | 100 | 2 | 67 | 28 | 20 |
| Klebsiella pneumoniae (total) | 4 | 13 | 4 | 23 | 44 | |||||
| Resistant (R/I) | ||||||||||
| SAM, FEP, CXM, CXA, CAZ, CRO, ESBL+ | - | - | 1 | 7 | - | - | - | - | 1 | 2 |
| TZP, ETP, IPM, MEM | - | - | 1 | 7 | - | - | - | - | 1 | 2 |
| Susceptible | 4 | 100 | 11 | 86 | 4 | 100 | 23 | 100 | 42 | 96 |
| Total isolates | 26 | 47 | 32 | 35 | 140 | |||||
JB: Jiquiriça-Brejões; CL: Cabrito Lagoon; TL: Tororó Lagoon; AL: Abaeté Lagoon; SAM: ampicillin/sulbactam; AMK: amikacin; CAZ: ceftazidime; CIP: ciprofloxacin; FEP: cefepime; CRO: ceftriaxone; CXA: cefuroxime/axetil; CTX: cefotaxime; CXM: cefuroxime; ETP: ertapenem; GEN: gentamicin; IPM: imipenem; I: indeterminate; MEM: meropenem; TZP: piperacillin/tazobac; R: resistant; ESBL+: extended-spectrum beta-lactamase positive.